Mollie Shields-Uehling is SAFE-BioPharma Association’s new president and CEO, company officials recently announced. Shields-Uehling was principal of Shields-Uehling Associates, an international public affairs company. She previously served in various leadership positions with Bristol-Myers Squibb, Wyeth, the International AIDS Vaccine Initiative, and in the White House Office of the U.S. Trade Represenative and the U.S. Foreign Commercial Service.

SAFE-BioPharma is an organization dedicated to managing a digital signature standard for worldwide use by the health care industry. Its participants include major pharmaceutical and government organizations. Shields-Uehling will lead the association through the next phase of the standard’s development.

“We’re pleased to welcome Mollie as SAFE-BioPharma Association’s new CEO,” says Gary Secrest, Johnson & Johnson worldwide information security chairman and director. “Mollie will provide us strong leadership that will extend the successful launch of the standard, the establishment of the nonprofit company, and the implementation of the preproduction phase of the SAFE Bridge Certification Authority.”

For more information, visit www.safe-biopharma.com.

 …